Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19
Authors:
- Marco InfanteMarco Infante
- Massimo PieriMassimo Pieri
- Santina LupisellaSLSantina Lupisella
- Ali MohamadAMAli Mohamad
- Sergio BernardiniSBSergio Bernardini
- David Della-MorteDavid Della-Morte
- Andrea FabbriAndrea Fabbri
- Alberto De StefanoASAlberto De Stefano
- Marco IannettaMarco Iannetta
- Lorenzo AnsaldoLALorenzo Ansaldo
- Angela CreaACAngela Crea
- Massimo AndreoniMAMassimo Andreoni
- 22 February 2023
- journal article
- research article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 39 (4) , 1-12
Abstract
Type 2 diabetes mellitus (T2DM) and impaired kidney function are associated with a higher risk of poor outcomes of COVID-19. We conducted a retrospective study in hospitalized T2DM patients with COVID-19 to assess the association between in-hospital mortality and admission values of different hematological/biochemical parameters, including estimated glomerular filtration rate (eGFR), plasma glucose and C-peptide (as a marker of beta-cell function). The study included T2DM patients with confirmed SARS-CoV-2 infection who were consecutively admitted to our Institution between October 1, 2020 and April 1, 2021. Patients (n = 74) were categorized into survivors (n = 55) and non-survivors (n = 19). Non-survivors exhibited significantly higher median WBC count, D-dimer, neutrophil-to-lymphocyte ratio, hsCRP, and procalcitonin levels, as well as significantly lower median serum 25(OH)D levels compared to survivors. Non-survivors exhibited significantly higher median admission plasma glucose (APG) values compared to survivors (210 vs 166 mg/dL; p = 0.026). There was no statistically significant difference in median values of plasma C-peptide between non-survivors and survivors (3.55 vs 3.24 ng/mL; p = 0.906). A significantly higher percentage of patients with an eGFR < 60 mL/min/1.73 m2 was observed in the non-survivor group as compared to the survivor group (57.9% vs 23.6%; p = 0.006). A multivariate analysis performed by a logistic regression model after adjusting for major confounders (age, sex, body mass index, major comorbidities) showed a significant inverse association between eGFR values and risk of in-hospital mortality (OR, 0.956; 95% CI, 0.931-0.983; p = 0.001). We also found a significant positive association between WBC count and risk of in-hospital mortality (OR, 1.210; 95% CI, 1.043-1.404; p = 0.011). Admission eGFR and WBC count predict in-hospital COVID-19 mortality among T2DM patients, independently of traditional risk factors, APG and random plasma C-peptide. Hospitalized patients with COVID-19 and comorbid T2DM associated with impaired kidney function at admission should be considered at high risk for adverse outcomes and death.Keywords
This publication has 73 references indexed in Scilit:
- Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?Journal of Biomedical Science, 2016
- Random non‐fasting C–peptide: bringing robust assessment of endogenous insulin secretion to the clinicDiabetic Medicine, 2016
- The Effect of Short-Term Hyperglycemia on the Innate Immune SystemThe American Journal of the Medical Sciences, 2016
- Targeting serum calcium in chronic kidney disease and end-stage renal disease: is normal too high?Kidney International, 2016
- Uric Acid as a Marker of Kidney Disease: Review of the Current LiteratureDisease Markers, 2015
- Interaction of the endocrine system with inflammation: a function of energy and volume regulationArthritis Research & Therapy, 2014
- Kidney Disease and Increased Mortality Risk in Type 2 DiabetesJournal of the American Society of Nephrology, 2013
- Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2011
- A New Equation to Estimate Glomerular Filtration RateAnnals of Internal Medicine, 2009
- TablesAmerican Journal of Kidney Diseases, 2002